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OBJECTIVE — Neonatal diabetes is a heterogeneous group of disorders with diabetes man-
ifestationintheﬁrst6monthsoflife.Themostcommonetiologyinpermanentneonataldiabetes
is mutations of the ATP-sensitive K
 channel subunits; in transient neonatal diabetes, chromo-
some 6q24 abnormalities are the most common cause.
RESEARCH DESIGN AND METHODS — We report a sporadic case of diabetes with-
out ketoacidosis diagnosed on the fourth day of life.
RESULTS — Analysis of the KCNJ11 gene found a novel R365H mutation in the proband and
her unaffected father. The functional analysis did not support pathogenicity of this variant.
When the patient’s diabetes remitted in the seventh month of life, the 6q24 region was analyzed
and a paternally inherited duplication was identiﬁed.
CONCLUSIONS — Our case reports a coincidental novel KCNJ11 variant in a patient with
transient neonatal diabetes due to a 6q24 duplication, illustrating the difﬁculty in testing neo-
nates before the clinical course of neonatal diabetes is known.
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N
eonatal diabetes is a heterogeneous
group of disorders with diabetes
manifestation before 6 months of
life that most frequently has a monogenic
etiology (1). In patients with permanent
neonatal diabetes (i.e., without remis-
sion) (PND), mutations of the KATP chan-
nelsubunits(encodedbytheKCNJ11and
ABCC8 genes) and mutations of the insu-
lin gene are the most common etiology
(1). Transient neonatal diabetes (TND)
usually resolves by 6 months of age, but
more than 50% of TND patients relapse
into diabetes during childhood or adult-
hood (2). Abnormalities of the imprinted
region, 6q24, which encompasses the
ZAC and HYMAI genes, cause 70% of
TNDcases(3).MutationsofKATPchannel
subunits are the second most common
etiology (3).
RESEARCH DESIGN AND
METHODS— We report on a patient
who was born with a birth weight of
2,320 g at 38 weeks’ postgestation (3rd
centile). Because of the low birth weight,
she required hospitalization at the new-
born care unit. She was diagnosed with
diabetes without ketoacidosis on the
fourth day of postnatal life (blood glu-
cose 19.5 mmol/l). The initial treatment
was intravenous insulin (0.04 units  
kg
1   h
1), followed by subcutaneous
injections of NPH insulin (0.9 units  
kg
1   day
1).
RESULTS— At the age of 2 weeks and
following a clinical diagnosis of neonatal
diabetes, analysis of the KCNJ11 gene was
undertaken (3). We found a novel, het-
erozygous missense mutation, R365H
(c.1094GA; p.Arg365His), in the pro-
band. The mutation was present in the
unaffected father and paternal grandfa-
ther (Fig. 1). Standard oral glucose toler-
ance tests revealed a normal glucose
tolerance with normal insulin and C-
peptidevaluesintheparentsandpaternal
grandmother, but the paternal grandfa-
ther had impaired fasting glycemia com-
bined with impaired glucose tolerance
(0-h glycemia 5.8 mmol/l; 2-h glycemia
9.4 mmol/l).
KATPchannelmutationscausingTND
in the proband and adult-onset diabetes
in a parent and/or grandparent have been
previously reported (3). The R365H mu-
tation identiﬁed in our family was
thought likely to be pathogenic because
the arginine residue at codon 365 is con-
served in dog, rat, and mouse, was not
presentin298controlchromosomes,and
has not previously been reported in pa-
tientswithhyperinsulinism.Therefore,in
vitro functional studies of this mutation
were undertaken. Channels containing
the R365H mutation were expressed in
Xenopus oocytes and their surface den-
sity, activation by the metabolic inhibitor
azide, and blocking by the sulfonylurea
tolbutamide were measured (4). Unex-
pectedly,therewasnodifferencebetween
the wild-type and mutant channels,
which calls into question the pathogenic-
ity of this mutation.
In the meantime, the patient devel-
oped hypoglycemia on insulin treatment,
and at the age of 7 months, the insulin
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value 24-h glycemic proﬁle 7 months af-
ter stopping insulin administration was
normal (4.7–4.1–5.5–7.8–7.6–7.1–
3.9–5.3–5.2 mmol/l), and A1C was 4.3%
(withintheDiabetesControlandCompli-
cations Trial range), (high-performance
liquid chromatography, Variant II; Bio-
rad, Hercules, CA, U.S.). Currently, with
the subject at the age of 2 years, A1C is
5.1%. No glycosuria has been noted on
repeated testing.
Thus, we had to revise our initial di-
agnosisofPNDduetoaKCNJ11mutation
(3). Genetic analysis of the methylation
status within the TND critical region on
chromosome 6 was performed using the
methylation-speciﬁcPCRmethod,aspre-
viouslydescribed(5).A6q24duplication
wasidentiﬁed,andfamilymembertesting
demonstrated that the duplication was
also present in the unaffected father and
paternal grandmother (Fig. 1).
CONCLUSIONS—We report a novel
KCNJ11 variant (R365H) and a 6q24 du-
plication in a proband with TND and her
unaffected father. The paternally inher-
ited 6q24 duplication is likely to be the
etiological mutation as a consequence of
overexpression of paternal genes within
the duplicated chromosome 6q24 region.
Expression of genes in this region is reg-
ulated by imprinting. The maternal allele
is methylated and therefore inactive: only
genes on the paternally derived chromo-
somearetranscribed.Normaldevelopment
depends on normal doses of gene tran-
scripts. The probands father is unaffected
because his 6q24 duplication is maternally
inherited and, therefore, inactive (2). The
impaired fasting glycemia and impaired
glucose tolerance in the paternal grandfa-
ther may be inﬂuenced by his age (53
years), weight (BMI 28.5 kg/m
2), and ma-
ternal history of type 2 diabetes. We con-
clude that the R365H is likely to be a rare
variant of no clinical signiﬁcance.
In PND patients, screening of the
KCNJ11 mutations is recommended, and
if it is negative, mutations in other genes
should be investigated (e.g., insulin gene,
ABCC8, etc.) (1,6). In the case of TND,
KATP channel genes should be tested if
6q24 analysis is negative. Our case report
highlights the difﬁculty in testing neo-
nates before the clinical course (transient
versuspermanent)isknownandwhenno
supportive signs (e.g., macroglossia and
umbilical hernia in 6q24 abnormalities
[2]) are present. Thus, in these patients,
we recommend screening for KCNJ11
gene mutations and 6q24 abnormalities
simultaneously, as making the genetic di-
agnosis earlier may inﬂuence treatment
(patientswithKATPchannelmutationsare
often sensitive to sulfonylureas, while pa-
tientswith6q24abnormalitiesareusually
treated with insulin [2,3]). Finally, when
a novel mutation in a known gene is
found, functional studies and investiga-
tions of other neonatal diabetes genes can
play an important role.
Acknowledgments— This work was sup-
portedinpartbyresearchgrantsMZ.2005/15-
NEDU-01 and APVV-51-014205 Slovakia (to
I.K.), CENDO (to I.K.), BITCET (to I.K.), and
the Wellcome Trust and European Union (to
A.T.H. and F.M.A.). A.T.H. is a Wellcome
Trust Research Leave Fellow.
We thank Associate Professor D. Chovan-
cova,MD,PhD;AssociateProfessorJ.Strnova,
MD, PhD; B. Ukropcova, MD; A. Penesova,
MD, PhD; and Alica Mitkova.
References
1. EdghillEL,FlanaganSE,PatchAM,Bous-
tred C, Parrish A, Shields B, Shepherd
MH, Hussain K, Kapoor RR, Malecki M,
MacDonaldMJ,StoyJ,SteinerDF,Philip-
son LH, Bell GI, Hattersley AT, Ellard S:
Insulin Mutation Screening in 1044 Pa-
tientswithDiabetes:MutationsintheINS
gene are a Common Cause of Neonatal
Diabetes but a Rare Cause of Diabetes Di-
agnosed in Childhood or Adulthood. Di-
abetes 57:1034–1042, 2007
2. Temple IK, Shield JP: Transient neonatal
diabetes, a disorder of imprinting. J Med
Genet 39:872–875, 2002
3. FlanaganSE,PatchAM,MackayDJ,Edghill
EL, Gloyn AL, Robinson D, Shield JP, Tem-
ple K, Ellard S, Hattersley AT: Mutations in
ATP-sensitive K channel genes cause
transient neonatal diabetes and permanent
diabetes in childhood or adulthood. Diabe-
tes 56:1930–1937, 2007
4. Proks P, Shimomura K, Craig TJ, Girard
CA, Ashcroft FM: Mechanism of action of
a sulphonylurea receptor SUR1 mutation
(F132L) that causes DEND syndrome.
Hum Mol Genet 16:2011–2019, 2007
5. Mackay DJ, Temple IK, Shield JP, Robin-
son DO: Bisulphite sequencing of the
transient neonatal diabetes mellitus DMR
facilitates a novel diagnostic test but re-
veals no methylation anomalies in pa-
tients of unknown aetiology. Hum Genet
116:255–261, 2005
6. Colombo C, Porzio O, Liu M, Massa O,
Vasta M, Salardi S, Beccaria L, Monciotti
C,ToniS,PedersenO,HansenT,Federici
L, Pesavento R, Cadario F, Federici G,
Ghirri P, Arvan P, Iafusco D, Barbetti F:
the Early Onset Diabetes Study Group of
the Italian Society of Pediatric Endocri-
nology and Diabetes (SIEDP): Seven mu-
tations in the human insulin gene linked
to permanent neonatal/infancy-onset dia-
betes mellitus. J Clin Invest. In press.
Figure 1—Pedigree of the family with coinci-
dence of the novel R365H variant of the
KCNJ11 gene and the 6q24 duplication.
Nature of hyperglycemia: neonatal diabetes.
TheKCNJ11genotypeisshownundereachsym-
bol. The 6q24 status is shown below. An arrow
points to the proband. The proband, the pro-
band’s father, and the proband’s paternal grand-
father are carriers of the R365H mutation. The
proband also has a paternally inherited 6q24
duplication. The proband’s father has a mater-
nally derived 6q24 duplication. The paternal
grandfather has both impaired fasting glucose
(IFG) and impaired glucose tolerance (IGT),
which seem to be associated with older age or
type 2 diabetes diagnosis and not with the
R365HmutationoftheKCNJ11gene.F,TND;
o, IFG  IGT. NN, no mutation identiﬁed.
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